  Where Canada's Intellectual Property Minds Come Together
|
Federal
Court
-
Pharmascience Inc. v. Glaxosmithkline Inc.:
November 29, 2007 (carvedilol)
-
Purdue Pharma v. Pharmascience Inc.,
2007 FC 1196: November 15, 2007 (oxycodone)
-
Bayer Healthcare AG v. Sandoz Canada Incorporated,
2007 FC 1068: October 17, 2007 (ciprofloxacin)
-
Bayer Healthcare AG v. Sandoz Canada Inc.,
2007 FC 590: June 6, 2007 (ciprofloxacin)
-
Bayer Healthcare AG v. Sandoz Canada Incorporated,
2007 FC 352: April 26, 2007 (ciprofloxacin)
-
Pharmascience Inc. v. Glaxosmithkline Inc.,
2007 FC 360: April 3, 2007 (carvedilol)
-
BMW Canada Inc. v. Nissan Canada Inc.,
2007 FC 262: March 7, 2007 (Infiniti
“M”)
-
Pfizer Canada Inc. v. Canada (Minister of Health),
2007 FC 188: February 19, 2007 (amlodipine besylate)
-
Pfizer Canada Inc. v. Canada (Health)
2007 FC 168: February 14, 2007 (amlodipine besylate)
-
Pfizer Canada Inc. v. Canada (Health),
2007 FC 167: February 14, 2007 (amlodipine besylate)
-
Abbott Laboratories v. Canada (Minister of Health),
2007 FC 50: January 18, 2007 (clarithromycin)
-
International Taekwon-Do Federation v. Choi,
2006 FC 1459: December 5, 2006 (Trade-mark matter)
-
Eli Lilly and Company v. Novopharm Ltd.,
2006 FC 843: June 30, 2006 (PROZAC)
-
Novopharm Ltd. v. AstraZeneca AB,
2006 FC 678: June 1, 2006 (PLENDIL)
-
Axcan Pharma Inc. v. Pharmascience Inc.,
2006 FC 527: April 26, 2006 (ursodiol)
-
Abbott Laboratories
v. Canada (Minister of Health),
2006 FC 341: March 16, 2006 (clarithromycin)
-
Abbott Laboratories
v. Canada (Minister of Health),
2006 FC 120: February 2, 2006 (clarithromycin)
-
Abbott Laboratories
v. Canada (Minister of Health),
2006 FC 76: January 24, 2006 (clarithromycin)
-
BMW Canada Inc. v.
Nissan Canada Inc.,
2005 FC 1708: December 16, 2005 (Infiniti “M”)
-
Axcan Pharma Inc. v.
Pharmascience Inc.,
2005 FC 1231: September 12, 2005 (ursodiol)
-
Abbott Laboratories
v. Canada (Minister of Health),
2004 FC 1349: October 1, 2004 (clarithromycin)
-
Apotex Inc. v.
Pharmascience Inc.,
2004 FC 1198: August
31, 2004 (ticlopidine)
-
Abbott Laboratories
v. Canada (Minister of Health),
2004 FC 1049: July 29, 2004 (clarithromycin)
-
Abbott Laboratories
v. Canada (Minister of Health),
2004 FC 465: March 25, 2004 (clarithromycin)
-
Glaxosmithkline Inc.
v. Canada (Minister of Health),
2004 FC 116: January 26, 2004 (carvedilol)
-
Novopharm Ltd. v.
AstraZeneca AB,
2003 FC 1212: October
17, 2003 (PLENDIL)
-
Glaxosmithkline Inc.
v. Canada (Minister of Health),
2003 FC 899: July 18, 2003 (carvedilol)
-
Depalma v. Bauer Nike
Hockey Inc.,
2003 FCT 742: June
12, 2003 (hockey pad – Patent matter)
-
Glaxosmithkline Inc.
v. Pharmascience Inc.,
2002 FCT 683: June
17, 2002 (paroxetine hydrochloride)
-
Astrazeneca AB v.
Novopharm Ltd.,
2002 FCT 165:
February 13, 2002 (PLENDIL)
-
Rlp Machine & Steel
Fabrication Inc. v. Walter Ditullio,
2001 FCT 245: March 27, 2001 (mill hole connector –
Patent matter)
-
Ciba-Geigy
Canada Ltd. v. Novopharm Ltd.:
November 10, 2000 (VOLTAREN)
-
Lifescan Inc.
v. Novopharm Ltd.:
November 10, 2000 (ONE
TOUCH)
-
Glaxo Wellcome
Inc. v. Novopharm Ltd.:
October 10, 2000
(ZOVIRAX)
-
Glaxo Group
Ltd. v. Novopharm Ltd.:
October 12, 1999
(ranitidine)
-
Apotex Inc. v.
Wellcome Foundation Ltd.:
September 28, 1999 (AZT)
-
Glaxo Group
Ltd. v. Novopharm Ltd.:
March
19, 1999 (ranitidine)
-
Hoffmann-La
Roche Ltd. v. Canada (Minister of National Health and
Welfare):
March 16, 1999 (ticlopidine)
-
Novopharm Ltd.
v. Ciba-Geigy Canada Ltd.:
February 23, 1999
(VOLTAREN)
-
Glaxo Group
Ltd. v. Novopharm Ltd.:
February 3, 1999
(ranitidine)
-
Pharmascience
Inc. v. Canada (Commissioner of Patents):
November 26, 1998 (Judicial
Review – diclofenac sodium)
-
Apotex Inc. v.
Wellcome Foundation Ltd.:
April 3, 1998 (AZT)
-
Glaxo Group
Limited v. Novopharm Limited:
April 9, 1997 (ranitidine)

|
|
|